skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 41 - 60 of 8,822  for All Library Resources

previous page 1 2 Results 3 4 5 next page
Refined by: resource type: Newsletter Articles remove
Result Number Material Type Add to My Shelf Action Record Details and Options
41
Clinical Trial: CY 6031 Study Will Evaluate the Effects of Treatment With Aficamten (CK-3773274) Over a 24-week Period on Cardiopulmonary Exercise Capacity and Health Status in Patients With Symptomatic oHCM
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: CY 6031 Study Will Evaluate the Effects of Treatment With Aficamten (CK-3773274) Over a 24-week Period on Cardiopulmonary Exercise Capacity and Health Status in Patients With Symptomatic oHCM

US Fed News Service, Including US State News, 2022

Copyright HT Digital Streams Limited Jan 12, 2022

Digital Resources/Online E-Resources

42
Clinical Electrophysiology Journal Issues Research Articles in Jan. 1, 2022 Edition
Material Type:
Newsletter Article
Add to My Research

Clinical Electrophysiology Journal Issues Research Articles in Jan. 1, 2022 Edition

Targeted News Service, 2022

Targeted News Service

Digital Resources/Online E-Resources

43
Circulation Journal Issues Research Articles in Nov. 16, 2021 Edition
Material Type:
Newsletter Article
Add to My Research

Circulation Journal Issues Research Articles in Nov. 16, 2021 Edition

Targeted News Service, 2021

Targeted News Service

Digital Resources/Online E-Resources

44
Clinical Trial: Analysis of Clinical featuRes and Echocardiographic Characteristics for Diagnosis of Infiltrative cardiomyopaThy (ACREDIT): Retrospective Multi-center Observational Study
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Analysis of Clinical featuRes and Echocardiographic Characteristics for Diagnosis of Infiltrative cardiomyopaThy (ACREDIT): Retrospective Multi-center Observational Study

US Fed News Service, Including US State News, 2021

Copyright HT Digital Streams Limited Nov 5, 2021

Digital Resources/Online E-Resources

45
European Medicines Agency OKs Bristol Myers Squibb's Application for Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

European Medicines Agency OKs Bristol Myers Squibb's Application for Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

Health & Beauty Close - Up, 2021

Copyright Close-Up Media, Inc. Oct 6, 2021

Digital Resources/Online E-Resources

46
Towards Uncovering the Splicing Code of the Gigantic Gene Titin in Familial Dilated Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Towards Uncovering the Splicing Code of the Gigantic Gene Titin in Familial Dilated Cardiomyopathy

MENA Report, 2021

2021 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info). ;EISSN: 2219-0112

Digital Resources/Online E-Resources

47
Clinical Trial: Athlete's Heart or Arrhythmogenic Right Ventricular Cardiomyopathy: Contribution of Exercise Cardiovascular Magnetic Resonance (CMR)
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Athlete's Heart or Arrhythmogenic Right Ventricular Cardiomyopathy: Contribution of Exercise Cardiovascular Magnetic Resonance (CMR)

US Fed News Service, Including US State News, 2021

Copyright HT Digital Streams Limited Aug 28, 2021

Digital Resources/Online E-Resources

48
United States : Stealth BioTherapeutics Strengthens IP Portfolio with Issuance of U.S. Patents Covering Elamipretide for Barth Syndrome
Material Type:
Newsletter Article
Add to My Research

United States : Stealth BioTherapeutics Strengthens IP Portfolio with Issuance of U.S. Patents Covering Elamipretide for Barth Syndrome

MENA Report, 2021

2021 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info). ;EISSN: 2219-0112

Digital Resources/Online E-Resources

49
Clinical Trial: Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

US Fed News Service, Including US State News, 2021

Copyright HT Digital Streams Limited Aug 4, 2021

Digital Resources/Online E-Resources

50
Clinical Trial: The Maastricht Cardiomyopathy Registry
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: The Maastricht Cardiomyopathy Registry

US Fed News Service, Including US State News, 2021

Copyright HT Digital Streams Limited Jul 27, 2021

Digital Resources/Online E-Resources

51
Alnylam Completes Enrollment In APOLLO-B Phase 3 Study Of Patisiran In Transthyretin-Mediated Amyloidosis Patients With Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Alnylam Completes Enrollment In APOLLO-B Phase 3 Study Of Patisiran In Transthyretin-Mediated Amyloidosis Patients With Cardiomyopathy

Benzinga Newswires, 2021

2020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.

Digital Resources/Online E-Resources

52
Clinical Trial: New Horizons for the Treatment of Cardiomyopathy in Children
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: New Horizons for the Treatment of Cardiomyopathy in Children

US Fed News Service, Including US State News, 2021

Copyright HT Digital Streams Limited May 20, 2021

Digital Resources/Online E-Resources

53
Bristol Myers Squibb Highlights New Clinical and Real-World Data on Mavacamten and Obstructive Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Bristol Myers Squibb Highlights New Clinical and Real-World Data on Mavacamten and Obstructive Hypertrophic Cardiomyopathy

Wireless News, 2021

Copyright Close-Up Media, Inc. May 12, 2021

Digital Resources/Online E-Resources

54
Bristol Myers Squibb Releases New Clinical and Real-World Data on Mavacamten and Obstructive Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Bristol Myers Squibb Releases New Clinical and Real-World Data on Mavacamten and Obstructive Hypertrophic Cardiomyopathy

Entertainment Close - Up, 2021

Copyright Close-Up Media, Inc. May 6, 2021

Digital Resources/Online E-Resources

55
Cardiovascular Imaging Journal Issues Research Articles in May 2021 Edition
Material Type:
Newsletter Article
Add to My Research

Cardiovascular Imaging Journal Issues Research Articles in May 2021 Edition

Targeted News Service, 2021

Targeted News Service

Digital Resources/Online E-Resources

56
Clinical Trial: Zinc Deficiency in Dilated Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Zinc Deficiency in Dilated Cardiomyopathy

US Fed News Service, Including US State News, 2021

Copyright HT Digital Streams Limited Apr 28, 2021

Digital Resources/Online E-Resources

57
Clinical Trial: Observational Study for Patients With Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Observational Study for Patients With Hypertrophic Cardiomyopathy

US Fed News Service, Including US State News, 2021

Copyright HT Digital Streams Limited Apr 21, 2021

Digital Resources/Online E-Resources

58
Institute for Clinical and Economic Review to Assess Treatment for Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Institute for Clinical and Economic Review to Assess Treatment for Hypertrophic Cardiomyopathy

Targeted News Service, 2021

Targeted News Service

Digital Resources/Online E-Resources

59
Clinical Trial: A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial

US Fed News Service, Including US State News, 2021

Copyright HT Digital Streams Limited Apr 2, 2021

Digital Resources/Online E-Resources

60
Clinical Trial: A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

US Fed News Service, Including US State News, 2021

Copyright HT Digital Streams Limited Mar 25, 2021

Digital Resources/Online E-Resources

Results 41 - 60 of 8,822  for All Library Resources

previous page 1 2 Results 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2001  (8)
  2. 2001 To 2005  (22)
  3. 2006 To 2010  (226)
  4. 2011 To 2016  (877)
  5. After 2016  (7,690)
  6. More options open sub menu

Subject 

  1. Cardiomyopathy  (8,816)
  2. Clinical Trials  (2,629)
  3. Heart Failure  (2,440)
  4. Patients  (1,842)
  5. Biotechnology Industry  (1,687)
  6. Disease  (1,328)
  7. Webcasting  (1,310)
  8. Stockholders  (1,279)
  9. R&d  (1,249)
  10. Research & Development  (1,249)
  11. Heart  (1,208)
  12. Net Losses  (1,123)
  13. Cardiovascular Disease  (1,116)
  14. Earnings Per Share  (1,113)
  15. Drug Dosages  (1,104)
  16. Diabetes  (1,036)
  17. Cardiology  (1,009)
  18. Fda Approval  (1,005)
  19. Collaboration  (982)
  20. Gene Therapy  (965)
  21. More options open sub menu

Databases 

  1. ProQuest Central  (8,821)
  2. MEDLINE  (1)
  3. More options open sub menu

Language 

  1. English  (8,821)
  2. Urdu  (1)
  3. Arabic  (1)
  4. Spanish  (1)
  5. More options open sub menu

Searching Remote Databases, Please Wait